The 150-patient trial has problems of confounding, according to two experts, and is unable to answer definitively whether hydroxychloroquine can benefit COVID-19 patients or harm them.
from WebMD Health https://ift.tt/2KcEOnS
The 150-patient trial has problems of confounding, according to two experts, and is unable to answer definitively whether hydroxychloroquine can benefit COVID-19 patients or harm them.
0 comments:
Post a Comment